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A Nucleolar Isoform of the Fbw7 Ubiquitin Ligase
Regulates c-Myc and Cell Size
ons. Because there are no antibodies available that can
be used to immunohistochemically localize the three
individual Fbw7 isoforms, we expressed FLAG-tagged
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exhibited a distinct subcellular distribution. Consistent2 Human Biology, and
3 Basic Sciences with a previous report [16], we found that Fbw7 was
nucleoplasmic and spared nucleoli, whereas Fbw7wasFred Hutchinson Cancer Research Center
Seattle, Washington 98109 found in a cytoplasmic distribution suggestive of ER/
Golgi staining. Surprisingly, Fbw7 was predominately4 Department of Medicine
University of Washington School of Medicine nucleolar with weak nucleoplasmic staining. The nucleo-
lar location of Fbw7 was independent of the fixationSeattle, Washington 98104
method (methanol/acetone versus paraformaldehyde)
and verified by colocalization with known nucleolar pro-
teins (data not shown and see below). To rule out theSummary
possibility that the observed localizations were affected
by either cell type or transient transfection, we con-The human tumor suppressor Fbw7/hCdc4 functions
as a phosphoepitope-specific substrate recognition firmed these observations by transducing primary hu-
man foreskin fibroblasts (HFF) with retroviral vectorscomponent of SCF ubiquitin ligases [1] that catalyzes
the ubiquitination of cyclin E [2–5], Notch [6, 7], c-Jun that expressed much lower amounts of Fbw7. Again,
we found that Fbw7 was nucleoplasmic whereas[8] and c-Myc [9–10]. Fbw7 loss in cancer may thus
have profound effects on the pathways that govern cell Fbw7 was nucleolar (Figure 1B). The alternative splic-
ing of isoform-specific exons thus produces Fbw7 iso-division, differentiation, apoptosis, and cell growth.
Fbw7-inactivating mutations occur in human tumor forms that localize to discrete subcellular compart-
ments.cell lines [2–4] and primary cancers [11–13], and Fbw7
loss in cultured cells causes genetic instability [13]. In
mice, deletion of Fbw7 leads to embryonic lethality
Isoform-Specific cis-Acting Signalsassociated with defective Notch and cyclin E regula-
Regulate Fbw7 Localizationtion [14, 15]. The human Fbw7 locus encodes three
We next sought to identify cis-acting signals that specifyprotein isoforms (Fbw7, Fbw7, and Fbw7) [2–4, 11].
Fbw7 localization and reasoned that the isoform-spe-We find that these isoforms occupy discrete subcellu-
cific exons might provide signals for Fbw7 compartmen-lar compartments and have identified cis-acting local-
talization. We therefore expressed only the isoform-spe-ization signals within each isoform. Surprisingly, the
cific exons by themselves and found that the Fbw7 NFbw7 isoform is nucleolar, colocalizes with c-Myc
terminus exhibited a nucleoplasmic pattern (panel N-when the proteasome is inhibited, and regulates nucle-
in Figure 1C), the Fbw7 N terminus was cytoplasmicolar c-Myc accumulation. Moreover, we find that knock-
(panel N- in Figure 1D) and the Fbw7 N terminus wasdown of Fbw7 increases cell size consistent with its
not confined to a particular location (data not shown).ability to control c-Myc levels in the nucleolus. We
N- contains a basic domain (BD) reminiscent of nuclearsuggest that interactions between c-Myc and Fbw7
localization signals (NLS) (KRRR, aa 11–14). Mutationwithin the nucleolus regulate c-Myc’s growth-promot-
of this domain caused N- cytoplasmic accumulationing function and that c-Myc activation is likely to be
(panel N- 11–14 in Figure 1C). This sequence thusan important oncogenic consequence of Fbw7 loss in
functions as an NLS within this exon. However, mutationcancers.
of KRRR (aa 11–14) in full-length Fbw7 did not abrogate
its nuclear localization, and this suggested the presenceResults and Discussion
of an additional NLS. There are three BDs in the Fbw7
common region that we designated BD1 (KRKL, aa 2–4),Fbw7 Isoforms Exhibit Distinct Subcellular
BD2 (RRR, aa 55–57), and BD3 (KRRK, aa 170–173) (Fig-Localizations
ure 1A and data not shown). By combining mutationsThe three Fbw7 protein isoforms are translated from
of the basic regions, we found that Fbw7 contains twomRNAs that each contain a unique 5 exon joined with
redundant nuclear localization signals, KRRR (11–14)10 shared exons (Figure 1A) [2–4, 11]. Although most
and BD1, and we found that disruption of both se-cancer-associated Fbw7 mutations fall within the
quences rendered Fbw7 cytoplasmic (panel BD1/shared exons, mutations within isoform-specific  and
11–14 in Figure 1C). exons have also been found [3, 11], indicating that
Previous workers noted a putative hydrophobic trans-isoform-specific functions may be targeted in tumors.
membrane domain within the Fbw7 N terminus [2, 16].We examined the subcellular localization of each Fbw7
When fused to their amino termini the Fbw7-specificisoform to address the role of the isoform-specific ex-
exon redirected Fbw7 and Fbw7 to the cytoplasm
(panels N- Fbw7 and N- Fbw7 in Figure 1D).*Correspondence: bclurman@fhcrc.org
5 These authors contributed equally to this manuscript. Fbw7 cytoplasmic localization is thus mediated by a
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Figure 1. Subcellular Localization of Fbw7
Isoforms
(A) Schematic representation of the Fbw7 iso-
forms (cis-acting localization signals are indi-
cated, see text).
(B) Fbw7 isoforms have distinct subcellular
localizations. Left: U2OS cells were trans-
fected with vectors encoding FLAG-tagged
Fbw7 isoforms, and cells grown on coverslips
were stained with anti-FLAG antibody. Right:
primary human foreskin fibroblasts were
transduced with retroviral vectors expressing
either Fbw7 or Fbw7 and immunostained
as above.
(C–E) Identification of cis-acting localization
signals within the Fbw7 isoforms. U2OS cells
were transfected with the indicated Fbw7 de-
letion mutants and stained with anti-FLAG an-
tibody.
dominant and transferable hydrophobic signal con- binding of all three Fbw7 isoforms with c-Myc in the
absence of proteasome inhibition, we used nonfunc-tained within the Fbw7-specific exon. Partial deletion
of the transmembrane domain allowed nucleolar Fbw7 tional Fbw7 mutants, which lack the F box to separate
binding from turnover, and we coprecipitated c-Myc andaccumulation (panel 19–26 in Figure 1D), which sug-
gested that the common region contains a nucleolar Fbw7 from cotransfected cells (panel F in Figure 2A).
Consistent with its cytoplasmic localization, Fbw7localization signal (NoLS). This prediction was con-
firmed by the finding that an Fbw7 mutant that lacks poorly coprecipitated with c-Myc when compared with
Fbw7 and Fbw7. This indicates that the binding be-any 5 exon was nucleolar (panel N-Fbw7 in Figure 1E).
Nucleolar localization is thus specified by the common tween c-Myc and Fbw7 occurred within the nuclear
compartment and not after cell lysis because equalregion, not the Fbw7-specific exon, and is overridden
by dominant signals contained within Fbw7- and amounts of all three Fbw7 isoforms were present in the
lysates.Fbw7-specific exons. This was further demonstrated
by fusion of the Fbw7-specific exon to full-length The compartmentalization of Fbw7 further suggests
that the common region of Fbw7 is sufficient for itsFbw7, which redistributed Fbw7 from a nucleolar to
a nucleoplasmic pattern (panel N- Fbw7 in Figure turnover function because both the substrate targeting
WD40 repeats and the F box are contained within this1E). Although we found that BD1 functions as the sole
Fbw7 NLS, none of the basic regions specifically af- region. We tested if Fbw7N, which contains only the
common region, could drive c-Myc turnover and foundfected nucleolar targeting (Figure 1E and data not
shown). Instead, we found that deletion of the C-terminal that Fbw7N promoted c-Myc degradation as efficiently
as full-length Fbw7, and this was reversed by pharma-11 amino acids caused Fbw7 to shift to a nucleoplas-
mic distribution (panel C11 in Figure 1E). However, this cologic proteasome inhibition (Figure 2B). The common
region thus contains the domains necessary for Fbw7mutation disrupts Fbw7 function, and it is likely that the
nucleoplasmic redistribution results from altered Fbw7 function, whereas the N termini of Fbw7 and Fbw7
determine their location.structure rather than deletion of a specific NoLS (data
not shown and [17]).
The distinct localizations of the three Fbw7 isoforms c-Myc Colocalizes with Fbw7 In the Nucleolus
upon Proteasome Inhibitionsuggested that they might differentially interact with
substrates. We thus examined the binding of each iso- We next determined the localization of c-Myc when it
is coexpressed with Fbw7 and when its turnover isform with the nuclear protein c-Myc. Although Fbw7
and Fbw7 coprecipitate with c-Myc, stable binding re- blocked by proteasome inhibition. c-Myc alone exhib-
ited its characteristic nucleoplasmic distribution thatquires pharmacologic proteasome inhibition to prevent
c-Myc turnover [9]. In order to directly compare the spared nucleoli (Figure 3A). However, consistent with a
Current Biology
1854
Figure 2. The Fbw7 Common Region Medi-
ates c-Myc Binding and Turnover
(A) c-Myc binds poorly to cytoplasmic Fbw7.
U2OS cells were transfected with c-Myc and
the indicated FLAG-Fbw7 constructs (abbre-
viations are as follows: C: no anti-FLAG anti-
body control; vec: empty vector control).
Shown are the amounts of c-Myc and Fbw7
contained in total cell lysates (left) and in anti-
Fbw7 (FLAG) immunoprecipitates (right).
(B) The Fbw7 common region promotes c-Myc
turnover. 293 cells were transfected as indi-
cated and treated with the proteasome inhibi-
tor MG-132 for 4 hr.
recent report [18], we found that proteasome inhibition Fbw7 Negatively Regulates Cell
Growth and c-Mycwith MG-132 caused a dramatic shift in c-Myc from
a nucleoplasmic to a nucleolar distribution, and this Myc proteins regulate cell growth, and c-Myc overex-
pression increases cell size in mammalian and insectoccurred when c-Myc was transfected either alone or
with each of the three Fbw7 isoforms (Figures 3A and cells [19, 20]. We used RNA interference (sh-RNA) to
examine the consequences of Fbw7 inhibition on cellS1A available in the Supplemental Data included with
this article online). Moreover, endogenous c-Myc also size in U2OS cells and primary human fibroblasts. We
first determined that each of these cell types expressedrelocalized to nucleoli after proteasome inhibition in
U2OS, 293, Hela, Rat1, Ov1063, and MDAH cells (Figure all three Fbw7 isoforms (Figure 4A and data not shown).
Expression of an shRNA targeting the Fbw7 common3A and data not shown). Deltavision deconvolution mi-
croscopy was employed for more precise examination region (which simultaneously inhibits all three isoforms)
caused primary HFF, Wi-38, and U2OS cells to becomeof the location of c-Myc and Fbw7within nucleoli when
c-Myc turnover was inhibited by MG-132. Although larger, as determined by forward scatter (sh-Fbw7 in
Figures 4B and 4C). The efficacy of Fbw7 inhibition byc-Myc and nucleolin were nucleolar, both proteins occu-
pied distinct and nonoverlapping regions within the nu- this shRNA has been assessed by real-time PCR analy-
sis of endogenous Fbw7 mRNA as well as inhibition ofcleolus (Figure 3B). In contrast, c-Myc and Fbw7 colo-
calized precisely within the nucleolus, consistent with ectopic FLAG-Fbw7 protein expression [9]. The in-
creased cell size was not due to altered cell cycle kinet-a role of Fbw7 in regulating c-Myc abundance in the
nucleolus. Binding of Fbw7 to c-Myc, as well as Fbw7- ics; Fbw7 knockdown did not significantly alter the cell
cycle profile of asynchronously growing cells, and simi-driven c-Myc ubiquitination, requires T58 phosphoryla-
tion [9, 10]. We therefore tested the hypothesis that T58 lar to reports on Myc-dependent cell growth, cell size
in both the G1 and G2 fractions was increased by Fbw7phosphorylation played a direct role in localizing c-Myc
to nucleoli perhaps by stimulating binding to Fbw7. inhibition (data not shown).
We next developed retroviral vectors that stably ex-However, this was not the case because mutation of
T58 had no effect on nucleolar c-Myc accumulation after press shRNAs directed against isoform-specific se-
quences to assess the role of individual endogenousMG-132 treatment (Figure S1B).
Figure 3. Fbw7 and c-Myc Colocalize in Nucleoli upon Proteasome Inhibition
(A) Proteasome inhibition induces c-Myc nucleolar accumulation. Top: exogenous c-Myc immunostaining of transfected U2OS cells. The
indicated cells were treated with MG-132 for 5 hr. Bottom: endogenous c-Myc staining of MG-132- treated U2OS cells.
(B) c-Myc and Fbw7 colocalize within nucleoli. U2OS cells were transfected with c-Myc and Fbw7 (panels 1 and 2) or c-Myc alone (panels
3 and 4). Cells were immunostained and analyzed by DeltaVision deconvolution microscopy. Merged images are shown with the corresponding
colors and antibodies indicated. Each panel depicts the nucleoli within a single cell.
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Figure 4. Fbw7 Regulates Cell Size and c-Myc Abundance
(A) Expression of endogenous Fbw7 mRNA. cDNA from U2OS cells and HFF (primary human foreskin fibroblasts) was used in PCR reactions
with exon-specific forward primers and a common 3 reverse primer.
(B) shRNA-mediated inhibition of Fbw7 or specific inhibition of Fbw7 increases cell size. HFFs were transduced with shRNA vectors that
target either the common region (Fbw7) or Fbw7, and cell size was determined by forward scatter.
(C) Mean and median forward scatter measurements of HFF, WI-38, and U2OS cells transduced with shRNA vectors as indicated. The percent
change in the forward scatter measurements, compared with control cells, is shown.
(D) Validation of Fbw7 knockdown by sh-Fbw7. Left: U2OS cells were transduced with retroviruses expressing either Fbw7 or control (si-C)
shRNA. Following puromycin selection, cells were transfected with a mixture of plasmids expressing all three FLAG-Fbw7 isoforms. Lysates
(normalized for protein) were immunoblotted for Fbw7 expression (top panel) and the amount of endogenous T58-phosphorylated c-Myc on
the same blot after stripping. Right: Semiquantitative RT-PCR of endogenous Fbw7 mRNA abundance in U2OS cells transduced with the
common region or Fbw7-specific sh-RNAs.
(E) Myc-dependent regulation of cell size by Fbw7. Left: c-Myc null rat fibroblasts or parental control rat fibroblasts (TGR) were transduced
with either wt-c-Myc or c-Myc T58A and immunoblotted for c-Myc (top) and pT58-c-Myc (bottom). Right: c-Myc null cells expressing either
ectopic wt-c-Myc or c-MycT58A were transduced with GFP vectors expressing sh-C, sh-Fbw7, or sh-Fbw7, and GFP positive cells collected
by flow sorting. Mean cell volume of the sorted cells was measured with a Coulter counter.
(F) Knockdown of Fbw7 leads to nucleolar c-Myc accumulation. U2OS cells were transduced with a retrovirus expressing the indicated
shRNAs. Cells grown on coverslips were fixed and stained for c-Myc.
Fbw7 isoforms in regulating cell size. The efficacy of Fbw7 mRNA (Figures 4D and S2). Although we success-
fully developed shRNAs that very effectively inhibitedthese shRNAs was validated by their ability to specifi-
cally inhibit the expression of the corresponding FLAG- Fbw7 and Fbw7 expression, we were unable to obtain
an shRNA that reproducibly inhibited Fbw7. Remark-Fbw7 isoform and by RT-PCR analysis of endogenous
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ably, the Fbw7-specific shRNA increased cell size in nostaining U2OS cells transduced with either the Fbw7
or Fbw7 shRNA vectors and in both cases found thatall three cell types and pT58 c-Myc abundance (Figures
4B–4D). In contrast, sh-Fbw7 did not affect either cell endogenous c-Myc accumulated in nucleoli in the ab-
sence of proteasome inhibition (Figure 4F). Thus, endog-size or c-Myc abundance (data not shown). Although
forward scatter is commonly used as a surrogate for enous Fbw7 regulates the abundance of endogenous
c-Myc in the nucleolus.cell size, changes in forward scatter cannot quantitate
changes in cell volume. We thus used a Coulter counter
to directly measure the mean cell volume (MCV) of U2OS Subcellular Localization and Fbw7 Function
cells transduced with the Fbw7 and Fbw7 shRNAs and The human Fbw7 gene has evolved significant additional
found that the shRNAs increased mean cell volume by complexity compared with the yeast Cdc4, C. elegans
28% and 15%, respectively (MCV sh-C: 3790 m3, sh- Sel-10, and Drosophila Ago loci, each of which encode a
Fbw7 4846 m3, and sh-Fbw7: 4387 m3). These data single Fbw7 protein. This evolution has produced Fbw7
indicate that Fbw7 regulates cell size and that this is isoforms that reside within distinct subcellular compart-
due at least in part to Fbw7 function. The larger cell ments as a result of alternatively spliced N-terminal
size effects observed with the Fbw7 common region exon-encoded protein sequences that, in conjunction
shRNA compared with sh-Fbw7 could reflect a role with signals common to all three isoforms, determine the
of Fbw7 in cell size regulation, perhaps by regulating isoform-specific localization in the cytoplasm, nucleus,
steady-state c-Myc abundance in the nucleoplasm or and nucleolus. Why might it be advantageous to have
through the regulation of other targets. However, semi- three different compartmentalized Fbw7 proteins com-
quantitative RT-PCR data suggest that the common re- pared with a single, ubiquitously expressed isoform?
gion shRNA inhibits Fbw7 expression more effectively One possibility is that expression of each isoform from
than sh-Fbw7 (Figures 4D and S2A), so the greater cell its own promoter would permit exquisite control of Fbw7
size increase resulting from the common region shRNA abundance in different parts of the cell, thus increasing
could simply be due to more complete Fbw7 knockdown. the potential for regulated substrate destruction. Inter-
Our data indicate that Fbw7 regulates cell size and estingly, it was recently reported that p53 specifically
are consistent with the idea that this occurs through its induces expression of Fbw7 when overexpressed, im-
effects on c-Myc in the nucleolus. We utilized c-Myc plicating this form of Fbw7 in p53-mediated growth con-
null rat fibroblasts [21] to directly determine the contri- trol [16]. Although the isoform-specific exons may sim-
bution of c-Myc phosphorylation to Fbw7-dependent ply direct functionally equivalent Fbw7 isoforms to
cell size regulation. Because c-Myc regulation by Fbw7 different subcellular addresses, they may also differ in
requires T58 phosphorylation, we first rescued the other ways than their locations. For example, we have
c-Myc null cells with either wt-c-Myc or c-MycT58A. found that Fbw7 and Fbw7 differ in their ability to
Because c-MycT58A is resistant to Fbw7, any differ- degrade specific cyclin E phosphospecies (M.W. and
ences in the response of these cells to Fbw7 knock- B.E.C., unpublished data).
down, compared with the cells rescued with wt-c-Myc,
will reflect the role of Myc. We thus used retroviruses
Nucleolar Functions of Fbw7 and c-Mycto express either wt-c-Myc or c-MycT58A at levels that
Although each of the Fbw7 isoforms may play roles inclosely approximated the amount of endogenous c-Myc
c-Myc regulation, our data suggest that one importantin the parental line (TGR) (Figure 4E). We next trans-
aspect of c-Myc regulation by Fbw7 is likely to be medi-duced these cells with retroviral GFP-shRNA vectors
ated by Fbw7 in the nucleolus. Because we have showntargeting Fbw7 or Fbw7 (both sh-RNA sequences are
that Fbw7 is located in the nucleolus in human primaryconserved in the rat Fbw7 gene), isolated cells express-
cells and cell lines, and the characteristic localizationing the shRNA by flow sorting based on GFP expression,
of c-Myc protein in nuclei generally appears to excludeand then directly measured the volume of the GFP-
nucleoli, we attempted to determine whether degrada-positive cells with a Coulter counter. Cells expressing
tion of a subpopulation of c-Myc might be associatedthe T58A mutant were nearly 15% larger than cells ex-
with nucleoli. Several lines of evidence support the no-pressing wt-c-Myc (Figure 4E), strongly suggesting that
tion that Fbw7 regulates c-Myc abundance and func-cell size is regulated by c-Myc T58 phosphorylation.
tion in the nucleolus: (1) under conditions of proteasomeImportantly, compared with a control shRNA (si-C), the
inhibition, in the nucleolus, there is a marked nucleolarFbw7 shRNA increased the size of cells expressing wt-
accumulation of c-Myc, which specifically colocalizesc-Myc to a volume approximating that of control T58A
with Fbw7 but not Fbw7, Fbw7, or nucleolin, (2)cells, but it did not increase the volume of c-MycT58A
shRNA-mediated Fbw7 inhibition leads to nucleolarcells (Figure 4E). The finding that cell size regulation by
accumulation of endogenous c-Myc in the absence ofFbw7 is dependent upon c-Myc T58 phosphorylation
proteasome inhibition, and (3) specific inhibition ofshows that this is exerted, at least in part, via c-Myc.
Fbw7 also increases cell size dependent on c-MycThe common region Fbw7 sh-RNA regulated cell size
T58 phosphorylation. Moreover, confocal microscopyalso in a c-Myc T58-dependent manner (Figure 4E). This
of cells stained with an antibody against the c-Mycsh-RNA caused a residual cell size increase in cells
N-terminal region revealed that a fraction of endogenousexpressing c-MycT58A, suggesting that Fbw7 loss may
c-Myc protein is normally present in nucleoli in the ab-regulate cell size through targets other than c-Myc.
sence of proteasome inhibition, apparently in associa-Given the effects of Fbw7 on c-Myc function, we
tion with RNA polymerase I complexes (C. Grandori etdetermined whether Fbw7 knockdown has an effect
on c-Myc nucleolar localization. We tested this by immu- al., submitted). It is likely that the Fbw7 isoform targets
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of notch signaling that targets notch for ubiquitin-mediated pro-the degradation of this subpopulation of c-Myc in the
tein degradation. Mol. Cell. Biol. 21, 7403–7415.nucleolus. Alternatively, nucleoplasmic c-Myc may be
8. Nateri, A.S., Riera-Sans, L., Da Costa, C., and Behrens, A. (2004).shunted into a nucleolar compartment for degradation,
The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK sig-
perhaps explaining why MG-132 does not promote evi- naling. Science 303, 1374–1378.
dent nucleoplasmic accumulation of c-Myc. 9. Welcker, M., Oryan, A., Jin, J., Grim, J., Harper, J.W., Eisenman,
R.N., and Clurman, B.E. (2004). The Fbw7 tumor suppressorIn sum, our data indicate that Fbw7 negatively regu-
regulates GSK3 phosphorylation-dependent c-Myc proteinlates cell size and fit well with the findings that, in Dro-
degradation. Proc. Natl. Acad. Sci. USA 101, 9085–9090.sophila, Ago regulates both cell growth and dMyc abun-
10. Yada, M., Hatakeyama, S., Kamura, T., Nishiyama, M., Tsune-dance ([22] and Grewel et al., submitted). Our finding
matsu, R., Imaki, H., Ishida, N., Okumura, F., Nakayama, K., and
that specific inhibition of Fbw7 increased cell size and Nakayama, K.I. (2004). Phosphorylation-dependent degradation
c-Myc nucleolar abundance implicates Fbw7 as the of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 23,
2116–2125.isoform likely to be responsible for the majority of these
11. Spruck, C.H., Strohmaier, H., Sangfelt, O., Muller, H.M., Hubalek,effects, and suggest that interactions between c-Myc
M., Muller-Holzner, E., Marth, C., Widschwendter, M., and Reed,and Fbw7 in the nucleolus play a key role in regulating
S.I. (2002). hCDC4 gene mutations in endometrial cancer. Can-cell growth. Fbw7 is thus part of an evolutionarily con-
cer Res. 62, 4535–4539.
served pathway controlling cell growth, differentiation, 12. Ekholm-Reed, S., Spruck, C.H., Sangfelt, O., Van Drogen, F.,
and division via regulation of its substrates. Further Mueller-Holzner, E., Widschwendter, M., Zetterberg, A., and
Reed, S.I. (2004). Mutation of hCDC4 leads to cell cycle deregu-study of these pathways is likely to yield important in-
lation of cyclin E in cancer. Cancer Res. 64, 795–800.sights into the biology of cancers associated with Fbw7
13. Rajagopalan, H., Jallepalli, P.V., Rago, C., Velculescu, V.E., Kinz-loss.
ler, K.W., Vogelstein, B., and Lengauer, C. (2004). Inactivation of
hCDC4 can cause chromosomal instability. Nature 428, 77–81.
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Supplemental Data including Experimental Procedures and two ad- Harper, J.W., Schwartz, R.J., and Elledge, S.J. (2004). Defective
ditional figures are available at http://www.current-biology.com/cgi/ cardiovascular development and elevated cyclin E and Notch
content/full/14/20/1852/DC1/. proteins in mice lacking the Fbw7 F-box protein. Proc. Natl.
Acad. Sci. USA 101, 3338–3345.
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